8 questions for a thorough history to diagnose migraines

Slideshow

When evaluating and diagnosing migraines in pediatric patients, a thorough medical history is key to giving a diagnosis. These 8 questions are structured to pinpoint concerning headache patterns earlier in the diagnosing process.

Recent Videos
Michael Kruer, MD
H. Westley Phillips, MD
H. Westley Phillips, MD
Alan Percy, MD
Alan Percy, MD
DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
William Gallentine, DO
Rob Knight, PhD | Image Credit: Contemporary Pediatrics®
Image credit: Kyle Dykes
Related Content
FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis

Joshua Fitch, Senior Editor
March 4th 2025
Article

First approved for PNH in 2007, the monoclonal antibody is now the first and only treatment for pediatric patients living with gMG.

Site Logo

PODCAST: Auditory brain stem implants in young children.

January 14th 2016
Podcast

Jamie Glater, MD, discusses an NIH-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis.

Image Credit: © Araki Illustrations - stock.adobe.com

FDA accepts new drug application for vatiquinone to treat Friedreich's ataxia

Morgan Ebert, Managing Editor
February 19th 2025
Article

The FDA has accepted PTC Therapeutics' NDA for vatiquinone, a potential treatment for Friedreich's ataxia, with a decision expected by August 19, 2025.

Weekly review: Several key FDA approvals, new puzzler case, and more | Image Credit: © Artur - © Artur - stock.adobe.com.

Weekly review: Several key FDA approvals, new puzzler case, and more

Joshua Fitch, Senior Editor
February 17th 2025
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

FDA approves non-invasive risdiplam tablet for spinal muscular atrophy | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves non-invasive risdiplam tablet for spinal muscular atrophy

Joshua Fitch, Senior Editor
February 12th 2025
Article

The new risdiplam tablet is suitable for those aged 2 years and older who weigh more than 44 lbs, according to Genentech.

Positive data reported for Trappsol Cyclo in patients 3 years and under with NPC1 | Image Credit: © ธนากร บัวพรหม - © ธนากร บัวพรหม - stock.adobe.com.

Positive data reported for Trappsol Cyclo in patients 3 years and under with NPC1

Joshua Fitch, Senior Editor
February 7th 2025
Article

Cyclo Therapeutics has enrolled 10 patients in a single-arm sub-study treating newborns to 3 years of age, evaluating the Trappsol Cyclo in the youngest subsets.

© 2025 MJH Life Sciences

All rights reserved.